Login / Signup

Tetraspanin-8 sequesters syntaxin-2 to control biphasic release propensity of mucin granules.

José WojnackiAgustin Leonardo LujanNathalie BrouwersCarla Aranda-VallejoGonzalo BiglianiMaria Pena RodriguezOmbretta ForestiVivek Malhotra
Published in: Nature communications (2023)
Agonist-mediated stimulated pathway of mucin and insulin release are biphasic in which rapid fusion of pre-docked granules is followed by slow docking and fusion of granules from the reserve pool. Here, based on a cell-culture system, we show that plasma membrane-located tetraspanin-8 sequesters syntaxin-2 to control mucin release. Tetraspanin-8 affects fusion of granules during the second phase of stimulated mucin release. The tetraspanin-8/syntaxin-2 complex does not contain VAMP-8, which functions with syntaxin-2 to mediate granule fusion. We suggest that by sequestering syntaxin-2, tetraspanin-8 prevents docking of granules from the reserve pool. In the absence of tetraspanin-8, more syntaxin-2 is available for docking and fusion of granules and thus doubles the quantities of mucins secreted. This principle also applies to insulin release and we suggest a cell type specific Tetraspanin/Syntaxin combination is a general mechanism regulating the fusion of dense core granules.
Keyphrases
  • type diabetes
  • molecular dynamics
  • molecular dynamics simulations
  • protein protein
  • glycemic control
  • skeletal muscle
  • insulin resistance